Denaturing high performance liquid chromatography: High throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease

Journal of Clinical Pathology

Volumn 58, Issue 5, 2005, Pages 479-485

  Yu, B ^a   Sawyer, N A ^a   Caramins, M ^a   Yuan, Z G ^a   Saunderson, R B ^b   Pamphlett, R ^b   Richmond, D R ^a   Jeremy, R W ^a   Trent, R J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; POLIOVIRUS RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOTOR NEURON DISEASE; MYH7 GENE; NUCLEOTIDE SEQUENCE; POLIOVIRUS RECEPTOR GENE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPERATURE;

ALGORITHMS; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA MUTATIONAL ANALYSIS; GENETIC SCREENING; GENOTYPE; HUMANS; MEMBRANE PROTEINS; MOTOR NEURON DISEASE; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, VIRUS; VENTRICULAR MYOSINS;

EID: 18444392736     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.021642     Document Type: Article

References (25)

1. Taylor CF, Taylor GR. Current and emerging techniques for diagnostic mutation detection: an overview of methods for mutation detection. Methods Mol Med 2004;92:9-44.
2. Wang DG, Fan JB, Siao CJ, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998;280:1077-82.
3. Gross E, Arnold N, Gostte J, et al. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet 1999;105:72-8.
4. Jones AC, Austin J, Hansen N, et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 1999;45:1133-40.
5. Klein B, Weirich G, Brauch H. DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations. Hum Genet 2001;108:376-84.
6. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20.
7. Gibbs RA, Belmont JW, Hardenbol P, et al. The international HapMap project. Nature 2003;426:789-96.
8. Cox D, Boillot C, Canzian F. Data mining: efficiency of using sequence databases for polymorphism discovery. Hum Mutat 2001;17:141-50.
9. Talbot K. Motor neurone disease. Postgrad Med J 2002;78:513-19.
10. Smart RV, Yu B, Le H, et al. DNA testing in familial hypertrophic cardiomyopathy: clinical and laboratory implications. Clin Genet 1996;50:169-75.
11. Semsarian C, Yu B, Ryce C, et al. Sudden cardiac death in familial hypertrophic cardiomyopathy: are "benign" mutations really benign? Pathology 1997;29:305-8.
12. Yu B, French JA, Jeremy RW, et al. Counselling issues in familial hypertrophic cardiomyopathy. J Med Genet 1998;35:183-8.
13. Sauderson R, Yu B, Trent RJ, et al. Persistent infection polymorphism in the polio virus receptor gene differs in motor neuron disease. Neuroreport 2004;15:383-6.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Adas Res 1988;16:1215.
15. Huber CG, Oefner PJ, Bonn GK. High-resolution liquid chromatography of oligonucleotides on noriporous alkylated styrene-divinylbenzene copolymers. Anal Biochem 1993;212:351-8.
16. Xiao W, Oefner PJ. Denaturing high performance liquid chromatography: a review. Hum Mutat 2001;17:439-74.
17. Kuklin A, Munson K, Gjerde D, et al. Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system. Genet Test 1997;1:201-6.
18. Liu W, Smith DI, Rechtzigel KJ, et al. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 1998;26:1396-400.
19. O'Donovan MC, Oefner PJ, Roberts SC, et al. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 1998;52:44-9.
20. McDowell DG, Burns NA, Parkes HC. Localised sequence regions possessing high melting temperatures prevent the amplification of a DNA mimic in competitive PCR. Nucleic Acids Res 1998;26:3340-7.
21. Erdmann J, Daehmlow S, Wischke S, et al. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet 2003;64:339-49.
22. Havndrup O, Bundgaard H, Andersen PS, et al. Outcome of clinical versus genetic Family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc Res 2003;57:347-57.
23. Jones AC, Sampson JR, Cheadle JP. Low level mosaicism detectable by DHPLC but not by direct sequencing. Hum Mutat 2001;17:233-4.
24. Pan KF, Liu W, Lu YY, Zhang L, et al. High throughput detection of microsatellite instability by denaturing high-performance liquid chromotography. Hum Mutat 2003;22:388-94.
25. Conley YP, Brockway H, Beatty M, et al. Qualitative and quantitative detection of mitochondrial heteroplasmy in cerebrospinal fluid using denaturing high-performance liquid chromatography. Brain Res Brain Res Protoc 2003;12:99-103.